Have a personal or library account? Click to login
Effect of Vipoxin (V. amm. meridionalis) and its components on neuromuscular transmission Cover

Effect of Vipoxin (V. amm. meridionalis) and its components on neuromuscular transmission

Open Access
|Jan 2025

References

  1. Atanasov VN, Danchev D, Mitewa M, Petrova S. (2009). Hemolytic and anticoagulant study of the neurotoxin Vipoxin and its components – basic phospholipase A2 and an acidic inhibitor Biochemistry (Moscow) 74(3): 276–280.
  2. Atanasov VN, Stoykova S, Goranova Y, Mitewa M, Petrova S. (2012) Acute toxicity of vipoxin and its components: is the acidic component an “inhibitor” of PLA2 toxicity? Interdiscip. Toxicol. 5 (4): 169–172.
  3. Banumathi S, Rajashankar RK, Nötzel C, Aleksiev B, Singh PT, Genov N, Betzel Ch. (2001). Structure of neurotoxic complex Vipoxin at 1.4 Å resolution. Acta Cryst D57, 1552–1559.
  4. Bowman CW. (1995). Physiology of the Neuromuscular Junction, in Muscle Relaxants (Fukushima K and Ochiai R eds) pp. 117–127, Springer, Tokyo.
  5. Bowman CW. (2006). Neuromuscular block. Br J Pharmacol 147: S277–S286.
  6. Cho W, Markowitz MA, Kézdy FJ. (1988). A new class of phospholipase A2 substrates: kinetics of the phospholipase A2 catalyzed hydrolysis of 3-(acyloxy)-4-nitrobenzoic acids. J Am Chem Soc 110: 5166–5171.
  7. Cull-Candy GS, Fohlman J, Gustavsson D, Lüllmann-Rauch R, Thesleff S. (1976). The effects of Taipoxin and Notexin on the function and fine structure of the murine neuromuscular junction. Neuroscience 1: 175–180.
  8. Gawade PS. (2004). Snake venom neurotoxins: Pharmacological classification. J Toxicol Toxin Rev 23 (1): 37–96.
  9. Gong N, Armugam A, Jeyaseelan K. (1999). Postsynaptic short-chain neurotoxins from Pseudonaja textilis, cDNA cloning, expression and protein characterization. Eur J Biochem 265: 982–989.
  10. Goranova Y, Samnaliev I, Nikolov S, Zlatev O, Kesov G, Iordanov V, Atanasov V. (2019). Experimental surgical protocol for continuous femoral venous access in the rat. BJVM 22(3): 322–329.
  11. Harris JB, Grubb BD, Maltin CA, Dixon R. (1984). The neurotoxicity of the venom phospholipases A2, notexin and taipoxin. Exp Neurol 161: 517–526.
  12. Harris JB. (1997). Toxic phospholipases in snake venom: An introductory review. Symp Zool Soc Lond 70: 235–250.
  13. Hodgson CW, Wickramaratna CJ. (2002). In vitro neuromuscular activity of snake venoms. Clin and Exp Pharm and Phys 29: 807–814.
  14. Holzer M, Mackessy SP. (1996). An aqueous endpoint assay of snake venom phospholipase A2. Toxicon 34: 1149–1155.
  15. Joseph B, Raj SJ, Edwin T, Sankarganesh P. (2011). Pharmacognostic and biochemical properties of certain biomarkers in snake venoms. Asian J Biol Sci 4: 317–324.
  16. Kini RM, Evans HJ. (1989). A model to explain the pharmacological effects of snake venom phospholipase A2. Toxicon 27: 613–635.
  17. Kini RM. (2003). Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 42 (8): 827–840.
  18. Kuruppu S, Ian Smith A, Isbister GK, Hodgson WC. (2008). Neurotoxins from australo-papuan elapids: a biochemical and pharmacological perspective. Crit Rev Toxicol 38: 73–86.
  19. Laemmli UK. (1970). Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 227: 680–685.
  20. Lee Ch, Dennis Ch, Katz LR. (1977). Characteristics of nondepolarizing neuromuscular block: (I) Post-junctional block by alpha-bungarotoxin. Canad Anaesth Soc J 24 (2): 212–219.
  21. Lewis RL, Gutmann L. (2004). Snake venoms and the neuromuscular junction, Disorders of neuromuscular transmission. Semin Neurol 24 (2): 175–179.
  22. Mancheva I, Kleinschmidt T, Aleksiev B, Braunitzer G. (1987). Sequence homology between phospholipase and its inhibitor in snake venom. The primary structure of phospholipase A2 of vipoxin from the venom of the Bulgarian viper (Vipera ammodytes ammodytes, Serpentes). Biol Chem Hoppe-Seyler 368: 343–352.
  23. Miller RD. (2010). Miller’s Anesthesia (7th ed.). Churchill Livingstone, Philadelphia.
  24. Nair AB, Jacob S. (2016). A simple practice guide for dose conversation between animals and human. J Basic Clin Pharma 7: 27–31.
  25. Noetzel C, Chandra V, Perbandt M, Rajashankar K, Singh T, Aleksiev B, Kalkura N, Genov N, Betzel Ch. (2002). Enzymatic activity and inhibition of the neurotoxic complex vipoxin from the venom of Vipera ammodytes meridionalis. Z Naturforsch 57: 1078–1083.
  26. Penev M, Dukova-Peneva P. (2007). Laboratory Hematology. Artik-2001, Sofia. Phui Yee JS. Nanling G, Afifiyan F, Donghui M, Lay PS, Armugam A and Jeyaseelan K. (2004). Snake postsynaptic neurotoxins: gene structure, Phylogeny and applications in research and therapy. Biochimie 86: 137–149.
  27. Ranawaka KU, Lalloo GD, de Silva HJ. (2013). Neurotoxicity in snakebite-the limits of our knowledge. PLOS Negl Trop Dis 7(10): e2302.
  28. Rugulo MJ, Dolly O, Nicholis DG. (1986). The mechanism of action of β-bungarotoxin at the presynaptic plasma membrane. Biochem J 233: 519–523.
  29. Sakmann B. (1992). Elementary steps in synaptic transmission revealed by currents through single ion channels. The EMBO Journal 11(6): 2003–2016.
  30. Sampaio CS, Hyslop S, Fontes RM, Prado-Franceschi J, Zambelli OV, Magro JA, Brigatte P, Gutierrez PV, Cury Y. (2010). Crotoxin: Novel activities for a classic β-neurotoxin. Toxicon 55: 1045–1066.
  31. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85.
  32. Stoykova S, Goranova Y, Pantcheva Iv, Atanasov V, Danchev D, Petrova S. (2013). Hemolytic activity and platelet aggregation inhibitory effect of vipoxin’s basic sPLA2 subunit. Interdiscip Toxicol 6(3): 136–140.
  33. Su MJ, Chang CC. (1984). Presynaptic effects of snake venom toxins which have phospholipase A2 activity (β-bungarotoxin, taipoxin, crotoxin). Toxicon 22(4): 631–640.
  34. Tasoulis T, Isbister GK. (2017). A review and database of snake venom proteomes. Toxins (Basel) 9: 290.
  35. Tchorbanov B, Aleksiev B. (1981). A simple procedure for the isolation of Vipoxin – a neurotoxin with phospholipase A2 activity from the venom of the Bulgarian viper (Vipera ammodytes). J App Biochem 3: 558–561.
  36. Tchorbanov B, Grishin E, Aleksiev B, Ovchinnikov Yu. (1978). A neurotoxic complex from the venom of the Bulgarian viper (Vipera ammodytes ammodytes) and a partial amino acid sequence of the toxic phospholipase A2. Toxicon 16: 37–44.
  37. Tomovic L. (2006). Systematics of the nose-horned viper (Vipera ammodytes Linnaeus, 1758). Herpetol J 16: 191–201.
  38. Utkin YN, Krivoshein AV. (2016). Snake venoms and envenomation, modern trends and future prospects. Nova Science Publishers.
DOI: https://doi.org/10.2478/intox-2020-0003 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 21 - 27
Submitted on: Dec 12, 2018
|
Accepted on: Mar 8, 2020
|
Published on: Jan 27, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Yana Goranova, Silviya Stoykova, Ivan Samnaliev, Vasil Atanasov, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.